Health Care

GW Pharmaceuticals PLC (GWPH) is expected to post its quarterly earnings on Feb. 26. Last week, GW Pharma saw its…

Shares of Amarin Corp (AMRN) gained up to 14% during the regular trading hours on Friday as rumors of an…

Immunomedics Inc. (IMMU) is scheduled to report second-quarter 2019 earnings results on Monday, February 25, after market close. The consensus…

Merck (MRK) announced today that it will acquire immunotherapy developer Immune Design (IMDZ) for $5.85 per share in cash for an…

Agilent Technologies (A) stock dropped about 4% in the extended trading hours despite reporting upbeat Q1 results. The muted guidance…

Tilray Inc. (TLRY) has taken the fusion spree seriously as a new deal has been signed to buy hemp food…

Bausch Health Companies Inc. (BHC) topped revenue estimates for the fourth quarter of 2018, sending shares climbing by 2.8% in…

Aurora Cannabis (ACB) on Wednesday announced the shuffle to its board of directors for aligning the directors' experience and expertise…

CVS Health Corporation (CVS) reported better-than-expected earnings for the fourth quarter of 2018 but revenue fell short of estimates, sending…

Intercept Pharmaceuticals (ICPT) had surged about 25% in the pre-market session on Tuesday after the biopharma company announced positive topline…

Medtronic plc (MDT) topped consensus estimates on revenue and earnings for the third quarter of 2019 and raised its earnings…

CVS Health Corporation (CVS) is scheduled to report fourth-quarter earnings results before the regular trading hours on Wednesday, February 20.…

Medical technology company Medtronic (MDT) will be reporting financial results for the third quarter Tuesday before the market opens. Analysts’…

Canopy Growth (TSX: WEED, NYSE: CGC) reported a loss of CAD0.38 and revenue of CAD83 million, which missed analysts' predictions. Analysts…

Quest Diagnostics (DGX) reported a 50% drop in earnings for the fourth quarter due to a decline in net revenues,…

AstraZeneca Plc (AZN) reported a 22% dip in earnings for the fourth quarter to 82 cents per share, weighed down…

Establishing its foray into robotic health products, pharmaceutical giant Johnson & Johnson (JNJ) on Wednesday announced it was acquiring California-based…

Teva Pharma (TEVA) posted its fourth-quarter 2018 before the opening bell on Feb. 13. The generic drugmaker saw revenue slip 16%…

Exelixis (EXEL) reported Q4 earnings of 37 cents per share and revenue of $228.6 million that beat analysts' views. Analysts…

Shares of Gilead Sciences (GILD) have tumbled 20% in the past 52 weeks on numerous reasons including weaker-than-expected quarterly results…

Canopy Growth (TSX: WEED, NYSE: CGC) will release its financial results for the third fiscal quarter of 2019 after the…